LTFS
IART icon

Ladenburg Thalmann Financial Services’s Integra LifeSciences IART Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$140K Buy
2,417
+9
+0.4% +$536 ﹤0.01% 2778
2019
Q3 		$145K Buy
2,408
+712
+42% +$42.4K ﹤0.01% 2686
2019
Q2 		$95K Sell
1,696
-207
-11% -$10.7K ﹤0.01% 3001
2019
Q1 		$98K Sell
1,903
-86
-4% -$4.38K ﹤0.01% 2897
2018
Q4 		$92K Buy
1,989
+1,216
+157% +$66.7K ﹤0.01% 2806
2018
Q3 		$51K Sell
773
-492
-39% -$30.6K ﹤0.01% 3296
2018
Q2 		$71K Hold
1,265
– – ﹤0.01% 3008
2018
Q1 		$71K Sell
1,265
-180
-12% -$9.44K ﹤0.01% 3008
2017
Q4 		$68K Buy
1,445
+98
+7% +$4.8K ﹤0.01% 3014
2017
Q3 		$68K Sell
1,347
-1,064
-44% -$54.6K ﹤0.01% 2864
2017
Q2 		$132K Buy
2,411
+106
+5% +$5.06K ﹤0.01% 2333
2017
Q1 		$97K Sell
2,305
-1,089
-32% -$46.5K ﹤0.01% 2420
2016
Q4 		$100K Buy
3,394
+1,484
+78% +$60.3K ﹤0.01% 2328
2016
Q3 		$79K Buy
1,910
+8
+0.4% +$335 ﹤0.01% 2420
2016
Q2 		$76K Buy
1,902
+88
+5% +$3.17K ﹤0.01% 2355
2016
Q1 		$61K Buy
1,814
+136
+8% +$4.24K ﹤0.01% 2431
2015
Q4 		$56K Hold
1,678
– – ﹤0.01% 2472
2015
Q3 		$50K Sell
1,678
-262
-14% -$8.19K ﹤0.01% 2468
2015
Q2 		$51K Buy
1,940
+51
+3% +$1.36K ﹤0.01% 2569
2015
Q1 		$47K Buy
1,889
+587
+45% +$13.9K ﹤0.01% 2596
2014
Q4 		$30K Buy
1,302
+431
+49% +$8.74K ﹤0.01% 2704
2014
Q3 		$18K Hold
871
– – ﹤0.01% 2744
2014
Q2 		$17K Hold
871
– – ﹤0.01% 2771
2014
Q1 		$16K Sell
871
-364
-29% -$7.02K ﹤0.01% 2707
2013
Q4 		$25K Buy
1,235
+188
+18% +$3.45K ﹤0.01% 2393
2013
Q3 		$19K Hold
1,047
– – ﹤0.01% 2484
2013
Q2 		$16K Buy
+1,047
New +$15.3K ﹤0.01% 2463

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IART Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Integra LifeSciences (IART) stake by 0.37% in Q4 2019, buying an estimated $536 and bringing the position to 2,417 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2778.

Ladenburg Thalmann Financial Services first reported a position in IART in Q2 2013 and has held it in 27 quarters since. The position peaked at $145K in Q3 2019. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2,417 shares of Integra LifeSciences worth $140K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 9 Integra LifeSciences shares in Q4 2019, an estimated $536.
  • Integra LifeSciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2778 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Integra LifeSciences in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Integra LifeSciences position peaked at $145K in Q3 2019.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.